Invasive Malignant Neoplasm — Trials

Invasive Malignant Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

1,820 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 604
Recruiting: 302
Ph III recruiting: 36
Growth YoY: +27.2%
Industry share: 19%
Top sponsor: National Cancer Institute (NCI)
Termination share: 37.1%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (283)

clinicaltrialsPublishedShowing 251–300 of 780 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT01409200	Antiandrogen Therapy With or Without Axitinib Before Surgery in Treating Patients With Previously Untreated Prostate Cancer With Known or Suspected Lymph Node Metastasis	completed	Phase 2	73	M.D. Anderson Cancer CenterOTHER	1	Mar 3, 2026	clinicaltrials
NCT05676463	MRI Guided Radiation Therapy for the Treatment of High Risk Prostate Cancer	terminated	Phase 2	6	Thomas Jefferson UniversityOTHER	1	Mar 3, 2026	clinicaltrials